Kangmei Pharma | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Alaunos Therapeutics USD 2.06M 661K 2024-12
Avita Medical AUD 4.5M 19.42M 2024-12
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Genomma Lab Internacional MXN 11.11B 479.74M 2025-03
Hypermarcas BRL 12.1B 112.97M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
IQVIA Holdings USD 6.07B 900M 2024-12
Jiangsu Hengrui CNY 46.99B 896.81M 2025-03
Kangmei Pharma CNY 7.04B 22.02M 2024-09
Moderna USD 10.07B 835M 2025-03
Organon & Co USD 542M 70M 2025-03
Revvity USD 7.64B 29.74M 2025-03
Sh Fosun Pharma CNY 47.92B 662.52M 2025-03
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Viatris USD 18.64B 1.16B 2024-12
Wuxi Apptec CNY 62.33B 3.7B 2025-03
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12
Zz Pientze Pharmaceu 15.26B 991.2M 2025-03



Kangmei Pharma Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.